ARTICLE | Company News
Ember Therapeutics, Mariel deal
March 23, 2015 7:00 AM UTC
Obesity and diabetes company Ember and Mariel, which is developing compounds targeting bone morphogenetic protein 7 ( BMP7; OP-1), will merge and form Ember Therapeutics Inc. The companies did not di...